Department of Surgical Oncology, First Affiliated Hospital of China Medical University, No. 155 Nanjing North Street, Heping District, 110001 Shenyang, People's Republic of China.
Department of Surgical Oncology, First Affiliated Hospital of China Medical University, No. 155 Nanjing North Street, Heping District, 110001 Shenyang, People's Republic of China.
Clin Res Hepatol Gastroenterol. 2021 Jan;45(1):101454. doi: 10.1016/j.clinre.2020.05.006. Epub 2020 Jun 3.
Although many studies have evaluated the prognostic significance of signet ring cell (SRC) histology for gastric cancer (GC) patients, the results were conflicting. The objective of this study was to compare clinicopathologic characteristics between SRC type and other types, and evaluate its impact on survival outcome.
We retrospectively reviewed clinicopathologic and survival data of 1891 patients who underwent curative resection for GC. All patients were divided into differentiated, undifferentiated and SRC type according to the histological classification. The prognostic differences between different types were compared and clinicopathologic factors were analyzed.
SRC histology type had a poorer disease-free survival (DFS) than differentiated type (5-year DFS, 37.7% vs 52.2%, P<0.001), but there was no prognostic difference between SRC type and undifferentiated type (37.7% vs 41.9%, P>0.05). For early GC patients, SRC type was more frequent in younger, female patients and T1a stage tumors; the 5-year DFS of SRC type was similar to that of any other histology type (P>0.05). SRC type showed more aggressive biological features, including extensive stomach involvement, large tumor size, advanced pTstage and pN stage, than other types for locally advanced GC patients; poorer DFS was observed in SRC type compared with differentiated type. Multivariate analysis indicated that SRC type (HR:1.71, 95%CI:1.10-1.68, P<0.01) and undifferentiated type (HR:1.21, 95%CI:1.04-1.40, P<0.05) were independently associated with poor DFS in locally advanced GC patients.
There was a significant difference between early and locally advanced GC patients with regard to clinicopathologic features and prognostic significance of SRC histology. SRC type was an independent prognostic factor for locally advanced GC patients, but not for early GC patients.
尽管许多研究评估了印戒细胞(SRC)组织学对胃癌(GC)患者的预后意义,但结果存在争议。本研究的目的是比较 SRC 型与其他类型的临床病理特征,并评估其对生存结果的影响。
我们回顾性分析了 1891 例接受 GC 根治性切除术患者的临床病理和生存数据。所有患者根据组织学分类分为分化型、未分化型和 SRC 型。比较不同类型之间的预后差异,并分析临床病理因素。
SRC 组织学类型的无病生存(DFS)明显差于分化型(5 年 DFS,37.7% vs 52.2%,P<0.001),但与未分化型(37.7% vs 41.9%,P>0.05)之间无预后差异。对于早期 GC 患者,SRC 型更常见于年轻、女性患者和 T1a 期肿瘤;SRC 型的 5 年 DFS 与任何其他组织学类型相似(P>0.05)。对于局部晚期 GC 患者,SRC 型表现出更具侵袭性的生物学特征,包括广泛的胃受累、较大的肿瘤大小、较晚的 pT 期和 pN 期;与分化型相比,SRC 型的 DFS 更差。多因素分析表明,SRC 型(HR:1.71,95%CI:1.10-1.68,P<0.01)和未分化型(HR:1.21,95%CI:1.04-1.40,P<0.05)是局部晚期 GC 患者DFS 不良的独立相关因素。
SRC 组织学的临床病理特征和预后意义在早期和局部晚期 GC 患者之间存在显著差异。SRC 型是局部晚期 GC 患者的独立预后因素,但不是早期 GC 患者的独立预后因素。